opioid crisis News

Purdue Opioid Deal May Be Worth Less Than Drugmaker Promised

Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may provide less than half the $10 billion that the closely held drugmaker projected in its Chapter 11 filing, said three people familiar …

Viewpoint: Will Purdue’s Bankruptcy Engulf Its Owners?

The bankruptcy of Purdue Pharma LP lays bare a distinction that the internet is making it more and more difficult to maintain: that between a company and the people who own or founded it. The Sackler family owns Purdue Pharma, …

Purdue’s Bankruptcy Deal Has Holes the Size of 24 States

If Purdue Pharma LP wants its bankruptcy plan to work, it’ll have to find a way to halt the kind of government lawsuits that normally can’t be stopped by a Chapter 11 case. Purdue said the point of its court …

OxyContin Maker Purdue Pharma Files for Bankruptcy to Wipe Out 2,000 Lawsuits

Purdue Pharma LP filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The Chapter 11 filing on Sunday in White …

Purdue Opioid Deal Pits State Against State on Epidemic Cost

Purdue Pharma LP, maker of the highly addictive Oxycontin painkiller, is pitting state against state with its offer of about $12 billion to resolve the company’s liability for the massive public-health crisis tied to opioid abuse that’s swept the U.S. …

Drugmaker Insys Wins Bankruptcy Court Approval to Sell Off Opioid

Drugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients, in response to concerns about the product’s role in fueling …

Drug Firms Must Face Trial Over Opioids Crisis Claims

A U.S. judge on Tuesday rejected efforts by major drugmakers, pharmacies and distributors to dismiss claims that they caused the nation’s opioid crisis, clearing the way for a scheduled landmark trial even as he pushes for a nationwide settlement. U.S. …

J&J Shares Rise as Oklahoma Opioid Award Less Than Expected

Johnson & Johnson shares rose as much as 5.4% after an Oklahoma judge ordered the company to pay far less than some investors expected in the first trial by a state seeking compensation for the public-health crisis spawned by opioid …

Apparent Decline in Overdose Deaths Reverses Long-Running Trend

NEW YORK — U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary numbers suggest. The Centers for Disease Control and Prevention on Wednesday posted data showing nearly 68,000 drug overdose deaths were reported …

Rickitt to Pay $1.4B to End U.S. Opioid Addiction Probe

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction …